Last reviewed: June 1, 2026
Recursion / Roche / Genentech Microglia Map
Recursion Pharmaceuticals, Roche, Genentech
Data typeHigh-content imaging, perturbation screen
Specieshuman
Sample countWhole-genome scale perturbation screen across iPSC-derived microglia
Technologyhigh-content imaging, whole-genome CRISPR, machine learning phenotyping
Disease contextAlzheimer's disease, Parkinson's disease, Multiple sclerosis, Amyotrophic lateral sclerosis
Notes
A machine learning-powered, high-content imaging-based map of microglial biology using whole-genome perturbation in human iPSC-derived microglia. Targeting neurological disease target discovery. Data availability not yet public at time of review.
Primary publication
Recursion and Roche/Genentech announce whole-genome Microglia Map collaboration (2023)
Sources
- Recursion and Roche/Genentech Microglia Map announcement (2023) · Link
Last reviewed: June 1, 2026